The event discussion explored how Medicaid cuts, policy shifts, and healthcare access challenges are personally impacting cancer patients today. Panelists discussed major access issues—from delayed diagnoses due to transportation and cost barriers to the critical role of biomarker testing and patient self-advocacy in navigating complex systems.